Gene · 26801
Papers1,424
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,424
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia. | Nat Commun | 2023 | 36890137 | PubTator, text mining | PubMed |
| MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis. | Mol Oncol | 2023 | 36862005 | PubTator, text mining | PubMed |
| MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells. | Cell Mol Life Sci | 2023 | 36847916 | PubTator, text mining | PubMed |
| Pre-Diabetes-Linked miRNA miR-193b-3p Targets PPARGC1A, Disrupts Metabolic Gene Expression Profile and Increases Lipid Accumulation in Hepatocytes: Relevance for MAFLD. | Int J Mol Sci | 2023 | 36835287 | PubTator, text mining | PubMed |
| The Role of miRNA-221 and miRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region. | Genes (Basel) | 2023 | 36833430 | PubTator, text mining | PubMed |
| MiR-21 Is Induced by Hypoxia and Down-Regulates RHOB in Prostate Cancer. | Cancers (Basel) | 2023 | 36831632 | PubTator, text mining | PubMed |
| High glucose induces an activated state of partial epithelial-mesenchymal transition in human primary tubular cell cultures. | PLoS One | 2023 | 36827456 | PubTator, text mining | PubMed |
| A Group of Tumor-Suppressive micro-RNAs Changes Expression Coordinately in Colon Cancer. | Curr Issues Mol Biol | 2023 | 36826008 | PubTator, text mining | PubMed |
| FUS regulates a subset of snoRNA expression and modulates the level of rRNA modifications. | Sci Rep | 2023 | 36806717 | PubTator, text mining | PubMed |
| MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF. | Int J Mol Sci | 2023 | 36768146 | PubTator, text mining | PubMed |
| Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. | Cells | 2023 | 36766731 | PubTator, text mining | PubMed |
| iPSC-Derived Pancreatic Progenitors Lacking FOXA2 Reveal Alterations in miRNA Expression Targeting Key Pancreatic Genes. | Stem Cell Rev Rep | 2023 | 36749553 | PubTator, text mining | PubMed |
| Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway. | Life Sci Alliance | 2023 | 36732018 | PubTator, text mining | PubMed |
| MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes. | Oncol Lett | 2023 | 36688110 | PubTator, text mining | PubMed |
| MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas. | Cancer Med | 2023 | 36583475 | PubTator, text mining | PubMed |
| Vitamin D modulates inflammatory response of DENV-2-infected macrophages by inhibiting the expression of inflammatory-liked miRNAs. | Pathog Glob Health | 2023 | 35850625 | PubTator, text mining | PubMed |
| Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p - A robust cell selection tool for stem cell therapy of corneal scarring. | J Adv Res | 2023 | 35623612 | PubTator, text mining | PubMed |
| Amelioration of ligamentum flavum hypertrophy using umbilical cord mesenchymal stromal cell-derived extracellular vesicles. | Bioact Mater | 2023 | 35475028 | PubTator, text mining | PubMed |
| Stress induced phosphoprotein 1 overexpression controls proliferation, migration and invasion and is associated with poor survival in oral squamous cell carcinoma. | Front Oncol | 2022 | 36713524 | PubTator, text mining | PubMed |
| The effects of maternal cigarette smoking on cadmium and lead levels, miRNA expression and biochemical parameters across the feto-placental unit. | Heliyon | 2022 | 36636214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26801/papers?page=5